Reader
=

s
Guide
to
Carbofuran
Docket
#
EPA­
HQ­
OPP­
2005­
0162
EPA
has
created
this
document
to
provide
an
organizational
structure
to
the
Carbofuran
Docket.
The
docket
index
can
be
broken
into
groups
of
related
documents.
The
first
group,
then,
contains
the
Federal
Register
Notice
and
docket
organizational
documents;
the
second
group
contains
revised
human
health
risk
assessment
and
supporting
documents
and
the
third
group
contains
the
revised
environmental
risk
assessment
and
supporting
documents.
The
Agency
is
providing
the
A
Reader
=

s
Guide
@

to
allow
the
reader
to
more
easily
access
and
navigate
the
various
items
contained
in
the
Carbofuran
docket.

Federal
Register
and
Docket
Organizational
Documents:

Docket
Item
1.
Carbofuran
Revised
Risk
Assessments;
Notice
of
Availability
and
Solicitation
of
Risk
Reduction
Options
Docket
Item
2.
Reader
=

s
Guide
to
the
Carbofuran
Docket
#
EPA­
HQ­
OPP­
2005­
0162
03/
1/
06
Hackley
This
document
is
designed
to
annotate
all
the
documents
in
the
Carbofuran
Docket.

Docket
Item
3.
Note
to
Reader
TBD
Plummer
This
document
will
provide
a
very
brief
summary
of
the
current
risk
picture
and
solicit
information
from
the
public
on
benefits
information
or
risk
management
suggestions.

Health
Effects
Documents
for
Phase
5
Public
Comments
Docket
Item
4.
Carbofuran.
HED
Response
to
Registrant's
Comments
Received
during
Phase
3
of
the
Reregistration
Process.
1/
31/
06
Drew
This
document
addresses
only
those
comments
submitted
by
the
technical
registrant
in
Phase
3.

Docket
Item
5
Carbofuran.
HED
Response
to
NRDC
Phase
3
Comments
on
the
Preliminary
Risk
Assessment
for
the
Reregistration
Eligibility
Decision
(
RED)
Document.
Phase
4.
1/
31/
06
Drew
This
document
memo
addresses
only
those
comments
submitted
by
NRDC
in
Phase
3.

Docket
Item
6.
Carbofuran.
HED
Revised
Risk
Assessment
for
the
Reregistration
Eligibility
Decision
(
RED)
Document
(
Phase
4).
TBD
Drew
This
document
provides
was
a
revised
to
incorporate
comments
and
new
data
received
in
Phase
3.
Significant
changes
occurred.

Docket
Item
7.
Revised
Carbofuran
Acute
Probablistic
Dietary
Exposure
Assessment
for
the
Reregistration
Eligibility
Decision
(
Phase
IV).
TBD
Stanton
This
document
describes
The
dietary
assessment
was
revised
to
incorporate
comments
and
new
data
received
in
Phase
3.

Docket
Item
8
Benchmark
Dose
Analysis
of
Cholinesterase
Inhibition
Data
in
Neonatal
and
Adult
Rats
(
MRID
no.
46688914)
Following
Exposure
to
Carbofuran.
1/
19/
05
Lowit
This
document
provides
BMD
estimates
calculated
for
a
comparative
cholinesterase
study
on
rats,
which
was
submitted
by
the
technical
registrant
in
Phase
3.

Environmental
Fate
and
Effects
Documents
for
Phase
5
Public
Comment
Docket
Item
9.
Response
to
Phase
3
Comments
on
Carbofuran
Environmental
Risk
Assessment
and
Human
Health
Drinking
Water
Exposure
Assessment.
2/
17/
06
Fite
This
document
addresses
comments
received
on
the
ecological
risk
assessment
and
drinking
water
assessment.

Docket
Item
10.
Reregistration
Eligibility
Science
Chapter
for
Carbofuran.
Environmental
Fate
and
Effects
Chapter.
2/
13/
06
Fite
This
document
describes
The
environmental
fate
and
effects
risk
assessment
was
revised
to
incorporate
comments
received
during
Phase
3.

Biological
&
Economic
Analysis
Documents
for
Phase
5
Public
Comment
Docket
Item
11.
Alternative
and
Brief
Benefit
Analysis
for
Selected
Carbofuran
Uses.
2/
9/
06
Brassard
This
document
includes
a
table
that
lists
available
alternatives
for
the
major
uses
of
carbofuran.
This
is
a
preliminary
analysis,
and
the
Agency
encourages
comments
on
it.
